dual A2A/A1 antagonists (Johnson & Johnson)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedual A2A/A1 antagonists (Johnson & Johnson)
Drug Alias NameJNJ-1734 dihydrochlorideJNJ-5293JNJ-8122JNJ-1734
ClassificationSmall molecules
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptorAdenosine A1 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A